Annual Operating Profit
-$6.77 M
+$3.86 M+36.32%
December 31, 2023
Summary
- As of February 12, 2025, INVO annual operating income is -$6.77 million, with the most recent change of +$3.86 million (+36.32%) on December 31, 2023.
- During the last 3 years, INVO annual operating profit has fallen by -$1.25 million (-22.71%).
Performance
INVO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Profit
-$1.30 M
+$602.50 K+31.66%
September 30, 2024
Summary
- As of February 12, 2025, INVO quarterly operating income is -$1.30 million, with the most recent change of +$602.50 thousand (+31.66%) on September 30, 2024.
- Over the past year, INVO quarterly operating profit has dropped by -$354.00 thousand (-37.41%).
Performance
INVO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Operating Profit
-$5.66 M
-$414.10 K-7.90%
September 30, 2024
Summary
- As of February 12, 2025, INVO TTM operating income is -$5.66 million, with the most recent change of -$414.10 thousand (-7.90%) on September 30, 2024.
- Over the past year, INVO TTM operating profit has dropped by -$251.00 thousand (-4.64%).
Performance
INVO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
INVO Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.3% | -37.4% | -4.6% |
| 3 y3 years | -22.7% | +51.9% | +11.0% |
| 5 y5 years | -156.9% | +51.9% | +11.0% |
INVO Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +29.7% | +57.0% | -358.2% | +109.0% | +8.5% | +87.8% |
| 5 y | 5-year | +278.5% | +57.0% | -358.2% | +109.0% | +216.4% | +87.8% |
| alltime | all time | >+9999.0% | +57.0% | -358.2% | +109.0% | >+9999.0% | +87.8% |
INVO Bioscience Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.30 M(-31.7%) | -$5.66 M(+7.9%) |
| Jun 2024 | - | -$1.90 M(+101.1%) | -$5.24 M(-3.0%) |
| Mar 2024 | - | -$946.40 K(-37.3%) | -$5.41 M(-20.1%) |
| Dec 2023 | -$6.77 M(-36.3%) | -$1.51 M(+70.2%) | -$6.77 M(-15.2%) |
| Sep 2023 | - | -$886.30 K(-57.1%) | -$7.98 M(-17.0%) |
| Jun 2023 | - | -$2.07 M(-10.4%) | -$9.62 M(-6.0%) |
| Mar 2023 | - | -$2.31 M(-15.2%) | -$10.23 M(-3.7%) |
| Dec 2022 | -$10.63 M(+103.7%) | -$2.72 M(+7.6%) | -$10.63 M(+43.5%) |
| Sep 2022 | - | -$2.53 M(-5.8%) | -$7.40 M(+3.5%) |
| Jun 2022 | - | -$2.68 M(-0.7%) | -$7.15 M(+12.5%) |
| Mar 2022 | - | -$2.70 M(-636.3%) | -$6.36 M(+21.9%) |
| Dec 2021 | -$5.22 M(-5.4%) | $503.60 K(-122.1%) | -$5.22 M(-30.5%) |
| Sep 2021 | - | -$2.27 M(+20.5%) | -$7.51 M(+15.5%) |
| Jun 2021 | - | -$1.89 M(+21.0%) | -$6.50 M(+14.5%) |
| Mar 2021 | - | -$1.56 M(-12.8%) | -$5.68 M(+3.0%) |
| Dec 2020 | -$5.51 M(+208.4%) | -$1.79 M(+41.0%) | -$5.51 M(+23.4%) |
| Sep 2020 | - | -$1.27 M(+19.3%) | -$4.47 M(+16.6%) |
| Jun 2020 | - | -$1.06 M(-23.9%) | -$3.83 M(+35.2%) |
| Mar 2020 | - | -$1.40 M(+88.5%) | -$2.84 M(+58.6%) |
| Dec 2019 | -$1.79 M(-32.1%) | -$740.80 K(+17.1%) | -$1.79 M(+14.6%) |
| Sep 2019 | - | -$632.40 K(+861.1%) | -$1.56 M(+39.6%) |
| Jun 2019 | - | -$65.80 K(-81.2%) | -$1.12 M(-60.7%) |
| Mar 2019 | - | -$349.10 K(-32.0%) | -$2.84 M(+7.9%) |
| Dec 2018 | -$2.63 M(+311.3%) | -$513.40 K(+170.4%) | -$2.63 M(+13.7%) |
| Sep 2018 | - | -$189.90 K(-89.4%) | -$2.32 M(+2.0%) |
| Jun 2018 | - | -$1.79 M(+1176.1%) | -$2.27 M(+270.0%) |
| Mar 2018 | - | -$140.30 K(-28.8%) | -$614.00 K(-4.1%) |
| Dec 2017 | -$640.40 K(-69.7%) | -$197.00 K(+36.5%) | -$640.40 K(-10.3%) |
| Sep 2017 | - | -$144.30 K(+9.0%) | -$713.70 K(-8.1%) |
| Jun 2017 | - | -$132.40 K(-20.6%) | -$776.80 K(-62.9%) |
| Mar 2017 | - | -$166.70 K(-38.3%) | -$2.10 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$2.11 M(+254.6%) | -$270.30 K(+30.3%) | -$2.11 M(+1.6%) |
| Sep 2016 | - | -$207.40 K(-85.7%) | -$2.08 M(+4.5%) |
| Jun 2016 | - | -$1.45 M(+703.6%) | -$1.99 M(+208.8%) |
| Mar 2016 | - | -$180.70 K(-23.8%) | -$643.90 K(+8.2%) |
| Dec 2015 | -$595.10 K(-64.6%) | -$237.00 K(+99.5%) | -$595.00 K(+66.2%) |
| Sep 2015 | - | -$118.80 K(+10.6%) | -$358.00 K(+49.7%) |
| Jun 2015 | - | -$107.40 K(-18.5%) | -$239.20 K(+81.5%) |
| Mar 2015 | - | -$131.80 K(-13.5%) | -$131.80 K(-81.3%) |
| Dec 2014 | -$1.68 M(+177.7%) | - | - |
| Dec 2013 | -$605.20 K(+9.6%) | - | - |
| Dec 2012 | -$552.30 K(-21.4%) | - | - |
| Dec 2011 | -$703.10 K(-53.6%) | -$152.40 K(-11.7%) | -$703.60 K(-27.0%) |
| Sep 2011 | - | -$172.50 K(-15.7%) | -$963.50 K(-16.7%) |
| Jun 2011 | - | -$204.60 K(+17.5%) | -$1.16 M(-8.4%) |
| Mar 2011 | - | -$174.10 K(-57.8%) | -$1.26 M(-16.8%) |
| Dec 2010 | -$1.52 M(-17.8%) | -$412.30 K(+13.0%) | -$1.52 M(-3.6%) |
| Sep 2010 | - | -$365.00 K(+17.7%) | -$1.57 M(+4.7%) |
| Jun 2010 | - | -$310.00 K(-27.6%) | -$1.50 M(-7.6%) |
| Mar 2010 | - | -$428.10 K(-8.7%) | -$1.63 M(-11.8%) |
| Dec 2009 | -$1.84 M(-1.0%) | -$469.00 K(+59.3%) | -$1.84 M(-42.3%) |
| Sep 2009 | - | -$294.40 K(-32.1%) | -$3.19 M(+9.7%) |
| Jun 2009 | - | -$433.60 K(-32.8%) | -$2.91 M(+5.8%) |
| Mar 2009 | - | -$645.70 K(-64.5%) | -$2.75 M(+29.5%) |
| Dec 2008 | -$1.86 M(+4179.3%) | -$1.82 M(>+9900.0%) | -$2.13 M(+554.9%) |
| Sep 2008 | - | -$13.20 K(-95.2%) | -$324.60 K(+1.7%) |
| Jun 2008 | - | -$274.00 K(+1439.3%) | -$319.10 K(+449.2%) |
| Mar 2008 | - | -$17.80 K(-9.2%) | -$58.10 K(+33.6%) |
| Dec 2007 | -$43.50 K(+472.4%) | -$19.60 K(+154.5%) | -$43.50 K(+82.0%) |
| Sep 2007 | - | -$7700.00(-40.8%) | -$23.90 K(+47.5%) |
| Jun 2007 | - | -$13.00 K(+306.3%) | -$16.20 K(+406.3%) |
| Mar 2007 | - | -$3200.00 | -$3200.00 |
| Dec 2006 | -$7600.00 | - | - |
FAQ
- What is INVO Bioscience annual operating income?
- What is the all time high annual operating profit for INVO Bioscience?
- What is INVO Bioscience annual operating profit year-on-year change?
- What is INVO Bioscience quarterly operating income?
- What is the all time high quarterly operating profit for INVO Bioscience?
- What is INVO Bioscience quarterly operating profit year-on-year change?
- What is INVO Bioscience TTM operating income?
- What is the all time high TTM operating profit for INVO Bioscience?
- What is INVO Bioscience TTM operating profit year-on-year change?
What is INVO Bioscience annual operating income?
The current annual operating profit of INVO is -$6.77 M
What is the all time high annual operating profit for INVO Bioscience?
INVO Bioscience all-time high annual operating income is -$7600.00
What is INVO Bioscience annual operating profit year-on-year change?
Over the past year, INVO annual operating income has changed by +$3.86 M (+36.32%)
What is INVO Bioscience quarterly operating income?
The current quarterly operating profit of INVO is -$1.30 M
What is the all time high quarterly operating profit for INVO Bioscience?
INVO Bioscience all-time high quarterly operating income is $503.60 K
What is INVO Bioscience quarterly operating profit year-on-year change?
Over the past year, INVO quarterly operating income has changed by -$354.00 K (-37.41%)
What is INVO Bioscience TTM operating income?
The current TTM operating profit of INVO is -$5.66 M
What is the all time high TTM operating profit for INVO Bioscience?
INVO Bioscience all-time high TTM operating income is -$3200.00
What is INVO Bioscience TTM operating profit year-on-year change?
Over the past year, INVO TTM operating income has changed by -$251.00 K (-4.64%)